Home > Journals > Minerva Anestesiologica > Past Issues > Minerva Anestesiologica 2004 April;70(4) > Minerva Anestesiologica 2004 April;70(4):189-91

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA ANESTESIOLOGICA

A Journal on Anesthesiology, Resuscitation, Analgesia and Intensive Care


Official Journal of the Italian Society of Anesthesiology, Analgesia, Resuscitation and Intensive Care
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,623


eTOC

 

INTENSIVE CARE  SMART 2004 - Milan, May 12-14, 2004FREEfree


Minerva Anestesiologica 2004 April;70(4):189-91

Copyright © 2004 EDIZIONI MINERVA MEDICA

language: English

Hemofiltration in the prevention of radiocontrast agent induced nephropathy

Marenzi G., Bartorelli A. L.

Monzino Heart Center, IRCCS, Institute of Cardiology, University of Milan, Milan, Italy


FULL TEXT  


Aim. The aim of the study was to investigate the role of hemofiltration in preventing contrast nephropathy in patients with renal failure.
Methods. We randomized 114 renal failure patients undergoing percutaneous coronary interventions (PCI) to either peri-procedural hemofiltration or saline hydration.
Results. Contrast nephropathy occurred in 5% of hemofiltration-treated patients and in 50% in controls (P<0.01). In-hospital event rate as well as in-hospital and 1-year mortality rates were lower in patients treated with hemofiltration.
Conclusion. In patients with renal failure undergoing PCI, peri-procedural hemofiltration is effective for the prevention of contrast nephropathy, and is associated with improved in-hospital and long-term outcome.

top of page

Publication History

Cite this article as

Corresponding author e-mail